Login Register Cart 0
Generic placeholder image

Pharmaceutical Nanotechnology

Editor-in-Chief

ISSN (Print): 2211-7385
ISSN (Online): 2211-7393

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Pharmacokinetics of Bio-shell-silver-core Nanoparticles (AgNP) in Sprague-Dawley Rats - In Vivo Study

Author(s): Asra Parveen, Vijaykumar B. Malashetty, Sushruta Marla, Shanth Reddy, Sidramappa Sirsand, Manjunath Yalagatti, Venkataraman Abbaraju and Raghunandan Deshpande*

Volume 9, Issue 3, 2021

Published on: 19 March, 2021

Page: [191 - 199] Pages: 9

DOI: 10.2174/2211738509666210319162415

Price: $65

Abstract

Background: Silver nanoparticles have been widely used in the field of nanomedicine. A comprehensive understanding of their pharmacokinetics is crucial for proper risk assessment and safe biomedical applications.

Objectives: The purpose of this study was to investigate the safety of silver nanoparticles by determining their potential toxicity following 28 days of administration in Sprague-Dawley rats.

Methods: The silver nanoparticles were administered by intravenous injection at the doses of 100, 200 and 500 μg/kg body weight for 28 consecutive days. Animals in the control group were received sterile water for injection. Each group consists of 10 male and 10 female rats.

Results: No treatment-related effects were seen in any of the parameters monitored in rats given 100, 200 and 500 μg/kg body weight/day of silver nanoparticles.

Conclusion: The study proved that the use of up to 500 μg/kg body weight biosynthesized silver nanoparticles have no toxic effect on the target organs and found safe. However, the safety of the nanoparticles might be attributed to the covering of biological moieties on nanoparticles. Hence, the biofunctionalized nanoparticles can be safely used by selecting the required size and dose in medicines and drug delivery systems.

Keywords: Biofunctionalized silver nanoparticles, Sprague-Dawley rats, pharmacokinetics, hematology, clinical chemistry, histopathological studies, toxicity.

« Previous Next »
Graphical Abstract

[1]
Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994; 31: 351-70.
[http://dx.doi.org/10.1016/S0079-6468(08)70024-9] [PMID: 8029478]
[2]
Alexander JW. History of the medical use of silver. Surg Infect (Larchmt) 2009; 10(3): 289-92.
[http://dx.doi.org/10.1089/sur.2008.9941] [PMID: 19566416]
[3]
Lee SH, Jun BH. Silver nanoparticles: synthesis and application for nanomedicine. Int J Mol Sci 2019; 20(4): 865.
[http://dx.doi.org/10.3390/ijms20040865] [PMID: 30781560]
[4]
Sreekanth TVM, Nagajyothi PC, Muthuraman P, et al. Ultra-sonication-assisted silver nanoparticles using Panax ginseng root extract and their anti-cancer and antiviral activities. J Photochem Photobiol B 2018; 188: 6-11.
[http://dx.doi.org/10.1016/j.jphotobiol.2018.08.013] [PMID: 30176393]
[5]
Huang Z, Jiang X, Guo D, Gu N. Controllable synthesis and biomedical applications of silver nanomaterials. J Nanosci Nanotechnol 2011; 11(11): 9395-408.
[http://dx.doi.org/10.1166/jnn.2011.5317] [PMID: 22413219]
[6]
Aschalew BZ, Kuppan G, Katherine WM, Khare S. Dose and size-dependent antiviral effects of silver nanoparticles on Feline calicivirus, a human norovirus surrogate. Foodborne Path Dis 2016; 13(5): 239-44.
[7]
Ahamed M, Alsalhi MS, Siddiqui MK. Silver nanoparticle applications and human health. Clin Chim Acta 2010; 411(23-24): 1841-8.
[http://dx.doi.org/10.1016/j.cca.2010.08.016] [PMID: 20719239]
[8]
Agency for toxic substances and disease registry. Toxicological profile. Atlanta, GA: U.S. Department of Health and Human Services 2005. Available from: https://www.atsdr.cdc.gov/
[9]
Lem KW, Choudhury A, Lakhani AA, et al. Use of nanosilver in consumer products. Recent Pat Nanotechnol 2012; 6(1): 60-72.
[http://dx.doi.org/10.2174/187221012798109318] [PMID: 22023078]
[10]
Shahare B, Yashpal M, Singh G. Toxic effects of repeated oral exposure of silver nanoparticles on small intestine mucosa of mice. Toxicol Mech Methods 2013; 23(3): 161-7.
[http://dx.doi.org/10.3109/15376516.2013.764950] [PMID: 23301827]
[11]
Christensen FM, Johnston HJ, Stone V, et al. Nano-silver - feasibility and challenges for human health risk assessment based on open literature. Nanotoxicology 2010; 4(3): 284-95.
[http://dx.doi.org/10.3109/17435391003690549] [PMID: 20795910]
[12]
Stensberg MC, Wei Q, McLamore ES, Porterfield DM, Wei A, Sepúlveda MS. Toxicological studies on silver nanoparticles: challenges and opportunities in assessment, monitoring and imaging. Nanomedicine (Lond) 2011; 6(5): 879-98.
[http://dx.doi.org/10.2217/nnm.11.78] [PMID: 21793678]
[13]
Pourhamzeh M, Mahmoudian ZG, Saidijam M, et al. The effect of silver nanoparticles on the biochemical parameters of liver function in serum, and the expression of caspase-3 in the liver tissues of male rats. Avicenna J Med Biochem 2016; 4(2): e35557.
[http://dx.doi.org/10.17795/ajmb-35557]
[14]
Wen H, Dan M, Yang Y, et al. Acute toxicity and genotoxicity of silver nanoparticle in rats. PLoS One 2017; 12(9): e0185554.
[http://dx.doi.org/10.1371/journal.pone.0185554] [PMID: 28953974]
[15]
Park MVDZ, Neigh AM, Vermeulen JP, et al. The effect of particle size on the cytotoxicity, inflammation, developmental toxicity and genotoxicity of silver nanoparticles. Biomaterials 2011; 32(36): 9810-7.
[http://dx.doi.org/10.1016/j.biomaterials.2011.08.085] [PMID: 21944826]
[16]
Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ, Autrup H. PVP-coated silver nanoparticles and silver ions induce reactive oxygen species, apoptosis and necrosis in THP-1 monocytes. Toxicol Lett 2009; 190(2): 156-62.
[http://dx.doi.org/10.1016/j.toxlet.2009.07.009] [PMID: 19607894]
[17]
Parveen A, Rao S. Effect of nanosilver on seed germination and seedling growth in Pennisetumglaucum. J Cluster Sci 2014; 26(3): 693-701.
[http://dx.doi.org/10.1007/s10876-014-0728-y]
[18]
Nikodinovska VV, Mladenovska K, Grozdanov A. Risks and health effects from exposure to engineered nanostructures: a critical review. J Chem Technol Metallur 2015; 50(2): 117-34.
[19]
De Jong WH, Van Der Ven LT, Sleijffers A, et al. Systemic and immunotoxicity of silver nanoparticles in an intravenous 28 days repeated dose toxicity study in rats. Biomaterials 2013; 34(33): 8333-43.
[http://dx.doi.org/10.1016/j.biomaterials.2013.06.048] [PMID: 23886731]
[20]
Sung JH, Ji JH, Park JD, et al. Subchronic inhalation toxicity of silver nanoparticles. Toxicol Sci 2009; 108(2): 452-61.
[http://dx.doi.org/10.1093/toxsci/kfn246] [PMID: 19033393]
[21]
Deshpande R, Bedre MD, Salimath B, et al. Microwave assisted rapid biosynthesis of stable silver nanoparticles using clove buds (Syzyriumaromaticum) solution. Nano Life 2012; 2(2): 1250012.
[http://dx.doi.org/10.1142/S1793984411000499]
[22]
Li Y, Leung P, Yao L, Song QW, Newton E. Antimicrobial effect of surgical masks coated with nanoparticles. J Hosp Infect 2006; 62(1): 58-63.
[http://dx.doi.org/10.1016/j.jhin.2005.04.015] [PMID: 16099072]
[23]
Klasen HJA. A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 2000; 26(2): 131-8.
[http://dx.doi.org/10.1016/S0305-4179(99)00116-3] [PMID: 10716355]
[24]
OECD 407. Repeated dose 28 day oral toxicity study in rodents. Available from: https://ntp.niehs.nih.gov/iccvam/suppdocs/feddocs/oecd/oecdtg407-2008.pdf
[25]
Foldbjerg R, Autrup H. Mechanisms of silver nanoparticle toxicity. Arch Basic Applied Med 2013; 1: 5-15.
[26]
Wijnhoven SW, Peijnenburg WJ, Herberts CA, et al. Nanosilver - a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicol 2009; 3(2): 109-U78.
[http://dx.doi.org/10.1080/17435390902725914]
[27]
Sung JH, Ji JH, Song KS, et al. Acute inhalation toxicity of silver nanoparticles. Toxicol Ind Health 2011; 27(2): 149-54.
[http://dx.doi.org/10.1177/0748233710382540] [PMID: 20870693]
[28]
Kim JS, Song KS, Sung JH, et al. Genotoxicity, acute oral and dermal toxicity, eye and dermal irritation and corrosion and skin sensitisation evaluation of silver nanoparticles. Nanotoxicology 2013; 7(5): 953-60.
[http://dx.doi.org/10.3109/17435390.2012.676099] [PMID: 22417112]
[29]
Kim JS, Sung JH, Ji JH, et al. In vivo genotoxicity of silver nanoparticles after 90-day silver nanoparticle inhalation exposure. Saf Health Work 2011; 2(1): 34-8.
[http://dx.doi.org/10.5491/SHAW.2011.2.1.34] [PMID: 22953185]
[30]
Yildirimer L, Thanh NTK, Loizidou M, Seifalian AM. Toxicology and clinical potential of nanoparticles. Nano Today 2011; 6(6): 585-607.
[http://dx.doi.org/10.1016/j.nantod.2011.10.001] [PMID: 23293661]
[31]
Perde-Schrepler M, Florea A, Brie I, et al. Size-dependent cytotoxicity and genotoxicity of silver nanoparticles in cochlear cells in vitro. J Nanomater 2019; 2019: 6090259.
[http://dx.doi.org/10.1155/2019/6090259]
[32]
Lankveld DP, Oomen AG, Krystek P, et al. The kinetics of the tissue distribution of silver nanoparticles of different sizes. Biomaterials 2010; 31(32): 8350-61.
[http://dx.doi.org/10.1016/j.biomaterials.2010.07.045] [PMID: 20684985]
[33]
Liu W, Wu Y, Wang C, et al. Impact of silver nanoparticles on human cells: effect of particle size. Nanotoxicology 2010; 4(3): 319-30.
[http://dx.doi.org/10.3109/17435390.2010.483745] [PMID: 20795913]
[34]
Lee JH, Kim YS, Song KS, et al. Biopersistence of silver nanoparticles in tissues from Sprague-Dawley rats. Part Fibre Toxicol 2013; 10(36): 36.
[http://dx.doi.org/10.1186/1743-8977-10-36] [PMID: 24059869]
[35]
Ferdous Z, Nemmar A. Health impact of silver nanoparticles: a review of the biodistribution and toxicity following various routes of exposure. Int J Mol Sci 2020; 21(7): 2375.
[http://dx.doi.org/10.3390/ijms21072375] [PMID: 32235542]
[36]
Elkhawass EA, Mohallal ME, Soliman MFM. Acute toxicity of different sizes of silver nanoparticles intraperitonally injected in balb/c mice using two toxicological methods. Int J Pharma Sci 2015; 7(2): 94-9.
[37]
Munger MA, Radwanski P, Hadlock GC, et al. In vivo human time-exposure study of orally dosed commercial silver nanoparticles. Nanomedicine (Lond) 2014; 10(1): 1-9.
[http://dx.doi.org/10.1016/j.nano.2013.06.010] [PMID: 23811290]
[38]
Kim YS, Kim JS, Cho HS, et al. Twenty-eight-day oral toxicity, genotoxicity, and gender-related tissue distribution of silver nanoparticles in Sprague-Dawley rats. Inhal Toxicol 2008; 20(6): 575-83.
[http://dx.doi.org/10.1080/08958370701874663] [PMID: 18444010]
[39]
Park K. Toxicokinetic differences and toxicities of silver nanoparticles and silver ions in rats after single oral administration. J Toxicol Environ Health A 2013; 76(22): 1246-60.
[http://dx.doi.org/10.1080/15287394.2013.849635] [PMID: 24283396]
[40]
Xu L, Li X, Takemura T, Hanagata N, Wu G, Chou LL. Genotoxicity and molecular response of silver nanoparticle (NP)-based hydrogel. J Nanobiotechnology 2012; 10: 16.
[http://dx.doi.org/10.1186/1477-3155-10-16] [PMID: 22548743]
[41]
Park EJ, Bae E, Yi J, et al. Repeated-dose toxicity and inflammatory responses in mice by oral administration of silver nanoparticles. Environ Toxicol Pharmacol 2010; 30(2): 162-8.
[http://dx.doi.org/10.1016/j.etap.2010.05.004] [PMID: 21787647]
[42]
Dziendzikowska K, Gromadzka-Ostrowska J, Lankoff A, et al. Time-dependent biodistribution and excretion of silver nanoparticles in male Wistar rats. J Appl Toxicol 2012; 32(11): 920-8.
[http://dx.doi.org/10.1002/jat.2758] [PMID: 22696427]
[43]
Schleh C, Semmler-Behnke M, Lipka J, et al. Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration. Nanotoxicology 2012; 6(1): 36-46.
[http://dx.doi.org/10.3109/17435390.2011.552811] [PMID: 21309618]
[44]
Pani JP, Mishra SP, More RS, et al. Hepatotoxic effect of characterized silver nanoparticle. Int J Therapeutic Appl 2015; 29: 13-8.
[45]
Parveen A, Ali T, Malik W, Rao S. Facile biological approach for immobilization, physicochemical characterization and antibacterial activity of noble metals nanocomposites. Mater Lett 2015; 148: 86-90.
[http://dx.doi.org/10.1016/j.matlet.2015.02.059]
[46]
Recordati C, De Maglie M, Bianchessi S, et al. Tissue distribution and acute toxicity of silver after single intravenous administration in mice: nano-specific and size-dependent effects. Part Fibre Toxicol 2016; 13: 12.
[http://dx.doi.org/10.1186/s12989-016-0124-x] [PMID: 26926244]

Rights & Permissions Print Cite
Article Metrics
13
1
© 2024 Bentham Science Publishers | Privacy Policy